The Lung Cancer Therapeutics Market 2024 to 2034 is expected to experience a substantial increase in size, growing from USD 37.5 billion in 2024 to USD 112.8 billion by 2034, at a CAGR of 11.7%. This robust expansion is driven by an increase in the global prevalence of lung cancer, advancements in cancer therapeutics, and a growing pipeline of innovative treatment options.

https://www.globenewswire.com/....news-release/2024/11